Big Pharma know SK well and are favorably impressed with PPHM's pipeline. They are waiting on final results of the various clinical trials to lower their perception of risk. Meanwhile, back at the ranch, PPHM is posturing to proceed alone with phase III clinical trials, just in case they don't like the deals BP offers. You can be assured the chips are flying!
Market Data 
Markets 
AI
